Hypertension Flashcards

1
Q

Hypertension in 30 sec

A
  • Excessive vascular volume
  • Low Compliance of vasculature
  • Increased activity of the Renin Anginotensin System
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Renin

A

Proteolytic enzyme that is released into the circulation primarily by the kidneys.
Stimulated by
1.sympathetic nerve activation
2.renal artery hypotension
3.decreased sodium delivery to the distal tubules of the kidney.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Essential Hypertension

A

No clear cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Secondary Hypertension

A

increase in BP due to a specific, known cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood pressure target

A

<140/90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

First line hypertension medications

A
  • Thiazide diuretics
  • ACE inhibitors
  • Angiotensin receptor blockers (ARBs)
  • Calcium channel blockers (CCBs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Second/third line HTN medications

A
  • Beta-blockers
  • Aldosterone antagonists
  • Loop diuretics
  • Direct vasodilators, alpha-1 blockers, alpha-2 blockers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Direct Cardiac agents

A

Impact Heart rate (HR), contractility, conductivity
•Beta Blockers
•Calcium Channel Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Peripheral Vascular Agents

A

Impact peripheral resistance, pre-load, vascular health, vasodilation
•Hydralazine
•Alpha 1 Antagonists
•Alpha 2 Agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Renal Agents

A

Impact fluid volume, metabolites
•ACE Inhibitors
•Angiotensin2 Inhibitors
•Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diuretics: Therapeutic Use

A
  • Hypertension –thiazides are first line
  • Heart Failure
  • Edema (peripheral/pulmonary)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diuretics: Side Effects

A
  • Hypotension
  • Renal dysfunction
  • Volume depletion
  • Electrolyte disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diuretics: cautions/contraindications

A
  • Sulfa allergy (loops)
  • Anuricpatients
  • Concomitant use of other nephrotoxic agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thiazide Diuretic Agents

A

•Inhibition of Sodium/Cl reuptake
–Excretes sodium
–Loosely coupled with Potassium excretion
–Moderate diuresis & afterload reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Loop diuretics

A
  • Inhibit Na, K, Ca, Mg reabsorption in the loop of Henle
  • Powerful diuresis and volume reduction
  • Decreased afterload
  • Not used much for BP reduction
  • Useful in patients with edema andheart failure
  • Most common is furosemide (Lasix)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Potassium Sparing Diuretics –Aldosterone Antagonists

A
•Inhibits aldosterone by inhibiting sodium-potassium exchange site in the distal tubule
–Excretes sodium
–Excretes water
–Retains potassium
•Used for resistant hypertension
•Also used to treat heart failure
17
Q

ACE Inhibitors

A

“prils”
•Inhibition of Angiotensin Converting Enzyme (ACE)–Inhibition of the conversion of Angiotensin I to Angiotensin II
•Peripheral Vasodilation–ATII causes peripheral vasoconstriction
•Reduced Antidiuretic Hormone (ADH) Production–Reduced fluid volume
•Reduced Aldosterone Production–Reduced fluid volume
•First line option

18
Q

Ace inhibitors: therapeutic uses

A
  • Hypertension
  • Post MI (with LVSD) -remodeling
  • Heart Failure
  • Diabetic patients
19
Q

Ace inhibitors: side effects

A
  • Angioedema
  • Cough
  • Orthostasis/hypotension
  • Hyperkalemia
20
Q

Ace inhibitors: cautions/contraindications

A

acute kidney injury
bilateral renal artery stenosis
hypotension
history of angioedema

21
Q

Angiotensin Receptor Blocker

A

“-sartan”
•Inhibition of Angiotensin II receptor–Action of angiotensin II is blocked despite its production
•Peripheral Vasodilation–ATII causes peripheral vasoconstriction
•Reduced Antidiuretic Hormone (ADH) Production–Reduced fluid volume
•Reduced Aldosterone Production–Reduced fluid volume
•First line option–Should not be combined with ACE inhibitors

22
Q

ARB: therapeutic use

A
  • Hypertension
  • Post MI (with LVSD) -remodeling
  • Heart Failure
  • Diabetic patients
23
Q

Arb: Side effects

A
  • Angioedema
  • Orthostasis/hypotension
  • Hyperkalemia
24
Q

ARB: cautions/contraindication

A

acute kidney injury
bilateral renal artery stenosis
hypotension
history of angioedema

25
Q

Calcium Channel blockers

A

“pine”
•Inhibition of sympathetic simulation of vascular smooth muscle–That means reduced afterload, but also reduced cardiac muscle contractility!
•Mechanism is by blocking calcium re-entry–Reduced contractility, reduced HR–Preserve renal function in those with HTN-related renal disease

  • vasodilation of vasculature- decrease BP, alleviate chest pain
  • first line option for HTN
26
Q

CCB therapeutic uses

A
  • Hypertension
  • Angina
  • Atrial Fibrillation
  • Subarachnoid hemorrhage
  • Raynaud’s Phenomenon
27
Q

CCB side effects

A
  • Hypotension
  • AV Block
  • Reflex tachycardia (dihydropyridine agents)
  • Headache, dizziness, flushing, drowsiness
  • Edema
  • Nausea
  • Constipation
28
Q

What to monitor with CCB

A

BP, HR

29
Q

Beta Blockers

A

“olol” “lol”
•Primarily a function of Beta 1 Blockade–Inhibition of sympathetic cardiac stimulation of the SA node–Inhibition of Reninsecretion
•Secondary effects of Beta 2 Blockade–Va sodilation of GI Vasculature
•Place in Therapy–Second line for hypertension when first line agents are optimized–Can decrease exercise tolerance initially

Important for htn with Ischemic heart disease, MI, CHF

30
Q

BB 1 targets

A

–“Cardioselective”
–Inhibits sympathetic contractility, inotropy, and conductivity of the heart
–Inhibits sympathetic renin secretion in the kidneys

31
Q

BB2 target

A

–Beta 2 receptors inhibit smooth muscle contractions in the lungs and GI tract
–Beta 2 blockade is useful for restricting hepatic blood flow for patient with Liver Cirrhosis, but generally not a therapeutic effect for CVD
–Beta 2 blockade may cause bronchospasm

32
Q

combined alpha and non-selective BB

A
  • Alpha 1 blockade–Causes peripheral vasodilation

* Combined alpha and nonselective beta-blockers lower blood pressure more than beta-blockers without alpha blockade

33
Q

HTN management on Rehab

A
  • Primary concern is the presence of hypotension and postural-related hypotension
  • Reduced cardiovascular response to exercise, especially with Beta-Blockers and Calcium Channel Blockers
  • Physical therapists can increase compliance through education–Emphasize “silent killer” nature of hypertension
34
Q

Non-pharm management of HTN

A
  • Diet modification
  • Low fat
  • Low sodium
  • Omega-3 fatty acids
  • Exercise
  • Limit alcohol
  • Smoking cessation
35
Q

PT and HTN

A
  • Lots of patients with hypertension (both treated and untreated), watch for:-Orthostasis-Hypotension-Dizziness-Fatigue
  • Use caution when doing activities that may cause vasodilation and further drops in blood pressure
  • Be aware of the patient’s ability to exercise
  • Help with compliance (pharm and non-pharm)
36
Q

KEY POINTS

A
  • Hypertension is a common disease marked by sustained increase in blood pressure that can lead to serious disease
  • Diauretics, sympatholytics, vasodialators, renin-ang. system inhibitors, and calcium channel blockers used to treat hypertension
  • The magnitude of the hypertension and presence of other comorbidities determine which drugs to prescribe.
  • PT/OTs have important role in making patients aware of impact of hypertension on function and how pharmacological and other active treatments can manage BP